Indies Pharma is reporting a 4% dip in net profits down to $7.2 million or 12 cents per share for the nine months ending July 31.
Revenues dipped by 1.3% to $856 million when compared with the similar period last year.
Directors say the results were affected by shortages of in-demand items though gross profits held a steady at $589 million.
The company's total assets however jumped by 25% to $2.8 billion while shareholder equity rose 38% to $1.7 billion.
comments powered by Disqus
All feeds
